Google AI rivals radiologists in breast cancer detectionGoogle AI rivals radiologists in breast cancer detection
New research on 175,000 women—the largest NHS study to date—on the use of AI in breast cancer screening shows that AI detected more cases of invasive cancer, more cases overall, had fewer false positives, and recalled fewer women having their first scan than humans did. For one part of the study, AI reduced the time spent reading scans by almost a third.
The Ultimate Grocery List for GLP-1 Users, According to a DietitianThe Ultimate Grocery List for GLP-1 Users, According to a Dietitian
These kitchen staples are nutrient-dense and easy to tolerate. These kitchen staples are nutrient-dense and easy to tolerate.
FDA warns Novo Nordisk over unreported potential Ozempic side effectsFDA warns Novo Nordisk over unreported potential Ozempic side effects
The FDA issued a warning letter to Novo Nordisk, the Danish drugmaker behind the diabetes and weight-loss medications Ozempic and Wegovy, over unreported potential side effects. The FDA issued a warning letter to Novo Nordisk, the Danish drugmaker behind the diabetes and weight-loss medications Ozempic and Wegovy, over unreported potential side effects.
GLP-1 Drugs and Osteoporosis; HbA1c at the Dentist? New Obesity Med GuideGLP-1 Drugs and Osteoporosis; HbA1c at the Dentist? New Obesity Med Guide
(MedPage Today) — GLP-1 receptor agonists may increase the risk of bone and tendon injuries, as well as conditions like osteoporosis and gout, a retrospective study suggested. (Washington Post) Chairside HbA1c testing during routine dental visits… (MedPage Today) — GLP-1 receptor agonists may increase the risk of bone and tendon injuries, as well as Read More
STAT+: Novo Nordisk is warned by the FDA for failing to report side effects tied to GLP-1 drugsSTAT+: Novo Nordisk is warned by the FDA for failing to report side effects tied to GLP-1 drugs
Novo Nordisk received a warning from the Food and Drug Administration for failing to report suspected incidents of side effects caused by its medicines, a step that is required by federal law. In a March 5 warning letter, the agency criticized the pharmaceutical company for various procedures that result in “serious violations” related to the Read More
Why ‘being squeezed’ helps breast cancer cells to thriveWhy ‘being squeezed’ helps breast cancer cells to thrive
A new study led by researchers at Adelaide University and published in Science Advances reveals why some cancers can grow and survive in the body, while others cannot. It turns out that intense mechanical pressure experienced by early cancer cells as they grow cramped in a restricted space can benefit some cancer cells, rather than impede growth, as might be expected. Scientists found that early breast cancer cells used this “squeeze” to their advantage.
GLP-1s have transformed weight loss and diabetes. Is addiction next?GLP-1s have transformed weight loss and diabetes. Is addiction next?
A large study found that people taking GLP-1 drugs like Ozempic for diabetes were less likely to be diagnosed with substance use disorder. (Image credit: Maria Fabrizio for NPR) A large study found that people taking GLP-1 drugs like Ozempic for diabetes were less likely to be diagnosed with substance use disorder. (Image credit: Read More
GLP-1 Receptor Agonist Switching and Treatment PersistenceGLP-1 Receptor Agonist Switching and Treatment Persistence
This cohort study evaluates glucagon-like peptide-1 (GLP-1) receptor agonist switching patterns and 12-month adherence and persistence among adults with overweight or obesity without diabetes. This cohort study evaluates glucagon-like peptide-1 (GLP-1) receptor agonist switching patterns and 12-month adherence and persistence among adults with overweight or obesity without diabetes.
Alternative breast cancer treatment tied to about four times higher mortality, nationwide analysis findsAlternative breast cancer treatment tied to about four times higher mortality, nationwide analysis finds
The alternative medicine industry is expanding rapidly, fueled in large part by the surge of health-related content on social media. This growing trend has become an increasing concern for oncology practitioners and patients, as it can affect treatment decisions and trust in evidence-based care. The worry isn’t unfounded, as a recent study involving patients with breast cancer found that women who chose complementary and alternative medicine (CAM) instead of traditional cancer therapies had a higher risk of dying.
Novo Nordisk Ends Lawsuit, Collaborates With Hims & Hers to Sell SemaglutideNovo Nordisk Ends Lawsuit, Collaborates With Hims & Hers to Sell Semaglutide
(MedPage Today) — Novo Nordisk is dismissing its patent infringement lawsuit against telehealth company Hims & Hers, as the two companies have reached an agreement that will see branded semaglutide (Ozempic, Wegovy) products sold through the… (MedPage Today) — Novo Nordisk is dismissing its patent infringement lawsuit against telehealth company Hims & Hers, as Read More